Houlihan Lokey Advises StanChem

Houlihan Lokey is pleased to announce that StanChem Resins and Dux Coatings (StanChem) has been acquired by Glen Oaks Capital (Glen Oaks) and Tecum Capital (Tecum). The transaction closed on September 1, 2026.

Headquartered in East Berlin, Connecticut, StanChem is a specialty chemicals platform that develops and manufactures high-performance resins and specialty coatings. StanChem Resins produces water-based acrylic, vinyl-acrylic, and styrene-acrylic emulsion polymers for architectural and industrial coatings, adhesives and sealants, nonwovens, and other specialty applications. Dux Coatings, based in Lodi, New Jersey, manufactures two-component urethane and epoxy coatings, serving more than 2,000 customers across tub-and-tile refinishing, automotive refinish, woodworking, artistic, and general industrial applications.

Glen Oaks Capital is a Rye, New York-based private equity firm focused on investing in small to midsized businesses. Glen Oaks partners with management teams and business owners to build long-term value through growth capital, strategic guidance, and M&A expertise, with a particular focus on niche manufacturing, environmental services, and value-added distribution. As an independent sponsor, Glen Oaks structures each investment as a unique partnership between management teams and investors, with an emphasis on aligning interests and supporting the long-term growth of its portfolio companies.

Tecum Capital is a Pittsburgh, Pennsylvania-based private investment firm deploying capital in lower middle-market companies. Tecum provides mezzanine debt and equity investments in growth-oriented middle-market companies across the broader environmental/industrial services, high-value manufacturing, value-added distribution, and business services sectors. Their team partners with independent sponsors, family offices, committed funds, business owners seeking succession plans, and management teams to create shared success. Tecum manages three Small Business Investment Company (SBIC) licensed funds and is currently investing out of Tecum Capital Partners IV, LP, a new fund launched in 2025. Since 2006, the team has collectively invested more than $1.2 billion in over 200 platforms and add-on acquisitions.

Houlihan Lokey served as the exclusive financial advisor to StanChem, assisting in initiating and negotiating the transaction on its behalf. This transaction highlights Houlihan Lokey’s expertise and continued success in advising businesses within the specialty chemicals, resins, and performance coatings sector.

RELATED: Chemicals, Mergers and Acquisitions